SPK-8016

SPK-8016 · Spark Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SPK-8016, covering 2024-02-23 to 2024-02-23. Get the full timeline:

Most recent: Clinical Trial Update: Dose-finding Study of SPK-8016 Gene Therapy in Patients With Hemophilia A to Support Evaluation in Individuals With FVIII Inhibitors [Phase 1, Phase 2]

See pricing